Pfizer Sanctions Affirmed In Neurontin Antitrust MDL
By Abigail Rubenstein ( June 10, 2011, 1:53 PM EDT) -- A New Jersey federal judge on Thursday upheld sanctions against Pfizer Inc. for a witness testimony violation in a class action that accuses the pharmaceutical giant of using patent litigation to delay generic competition for epilepsy drug Neurontin....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.